TargED Biopharmaceuticals to Present First Clinical and New Preclinical Data on TGD001 in Two Oral Sessions at the 2025 ASH Annual Meeting

Utrecht, November 3, 2025 -…

TargED Biopharmaceuticals announces the appointment of Erik van den Berg as Chair of its Supervisory Board

Utrecht, the Netherlands, January 19,…

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients

TargED Biopharmaceuticals raises EUR 39…